NUP210 and primary biliary cholangitis: Studies have shown mortality due to PBC associated hepatic failure/liver transplantation, clinical progression to hepatic failure, and histological evidence of severe interface hepatitis and lobular injury in patients harboring anti-gp210 (Invernizzi et al., 2001; Nakamura et al., 2007).